Afferent (acquired by Merck)

Alios (acquired by Johnson+Johnson)

Ambit (acquired by Daiichi Sankyo)

Ambrx (acquired by Wuxi)

Artus (acquired by Qiagen)

Avexis (acquired by Novartis)

BioFire (acquired by bioMérieux)

BioXell (acquired by Cosmo)

Care Innovations (acquired by PRA Health Sciences)

CGI (acquired by Gilead)

DVS (acquired by Fluidigm)

Envoy (acquired by Takeda)

Flatiron (acquired by Roche)

Foundation Medicine (acquired by Roche)

Good Therapeutics (acquired by Roche)

HistoRx (acquired by Genoptix)

Leukosite (acquired by Millennium)

Lino Biotech (acquired by Miltenyi Biotech)

LTI (acquired by Bial)

Maculogix (acquired by LumThera)

Memory (acquired by Roche)

Miikana (acquired by EntreMed)

MySugr (acquired by Roche)

Pandion (acquired by Merck)

Purigen (acquired by Bionano)

Sequana (acquired by Celera)

Stratos Genomics (acquired by Roche)

Syrrx (acquired by Takeda)

Tripath (acquired by Becton Dickinson)

Viewics (acquired by Roche)

Zikanii (acquired by Eloxx)

23andMe

Addex

Aileron

Anadys

Black Diamond Therapeutics

C4 Therapeutics

Caliper

Centessa

Complete Genomics

Conatus

Curetis

CV Therapeutics

CytomX

deCode

Fibrogen, Inc

Halozyme Therapeutics

Horizon Discovery

IDEAYA Biosciences

Miragen

Pharmasset

Protein Design Labs, Inc

Senseonics

Taimed

TiGenix

Vaxcyte

Xenon